Literature DB >> 23765453

Cubic magnetically guided nanoaggregates for inhalable drug delivery: in vitro magnetic aerosol deposition study.

Doaa Mohamed Ragab1, Sohrab Rohani.   

Abstract

The present work describes the in vitro aerosol deposition and enhanced deaggregation behavior of superparamagnetic iron oxide nanoaggregates (SPIONs). SPIONs were surface-coated with amine functionalized polyrotaxane and were proposed as a carrier for inhalation dry powders. Polyrotaxane is primarily composed of beta cyclodextrin rings which are spontaneously threaded on the block copolymer, poly(propylene glycol) bis(2-aminopropylether). Variable concentrations of surface coating polymers showed controlled manipulation of the crystal size and morphology. Magnetic nanoaggregates fabricated with low concentration of polyrotaxane showed cubic crystal morphology. However, these nanoaggregates exhibited rhombic dodecahedron crystal structure upon increasing the coating polymer concentration. In comparison to the spherical uncoated magnetic nanoparticles, cubic phase magnetic nanoaggregates demonstrated an enhanced in vitro aerosol deposition using magnetic field alignment. This enhancement can be accomplished at low inhalation flow rates (15 and 30 L/min). However, transformation to the cubic crystal structure was observed to be associated with a reduction in the powder geometric standard deviation. Using a mathematical modeling approach, we noted significant enhancement in the deaggregation behavior of inhalation dry powders; that can be achieved with small amounts of magnetic nanoaggregates. Aggregates of cubic nanoparticles showed promise for targeted pulmonary deposition of anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765453      PMCID: PMC3755173          DOI: 10.1208/s12249-013-9980-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  37 in total

1.  Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.

Authors:  M Brzoska; K Langer; C Coester; S Loitsch; T O F Wagner; C v Mallinckrodt
Journal:  Biochem Biophys Res Commun       Date:  2004-05-28       Impact factor: 3.575

2.  Dry powder inhaler device influence on carrier particle performance.

Authors:  Martin J Donovan; Sin Hyen Kim; Venkatramanan Raman; Hugh D Smyth
Journal:  J Pharm Sci       Date:  2011-11-17       Impact factor: 3.534

3.  Microencapsulated chitosan nanoparticles for lung protein delivery.

Authors:  Ana Grenha; Begoña Seijo; Carmen Remuñán-López
Journal:  Eur J Pharm Sci       Date:  2005 Jul-Aug       Impact factor: 4.384

4.  Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.

Authors:  Jens Lipka; Manuela Semmler-Behnke; Ralph A Sperling; Alexander Wenk; Shinji Takenaka; Carsten Schleh; Thomas Kissel; Wolfgang J Parak; Wolfgang G Kreyling
Journal:  Biomaterials       Date:  2010-06-09       Impact factor: 12.479

5.  Behaviour of magnetic micro-particles in the human lung.

Authors:  W Stahlhofen; W Möller
Journal:  Radiat Environ Biophys       Date:  1993       Impact factor: 1.925

6.  Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.

Authors:  Mu-Yi Hua; Hung-Wei Yang; Hao-Li Liu; Rung-Ywan Tsai; See-Tong Pang; Kun-Lung Chuang; Yu-Sun Chang; Tsong-Long Hwang; Ying-Hsu Chang; Heng-Chang Chuang; Cheng-Keng Chuang
Journal:  Biomaterials       Date:  2011-08-27       Impact factor: 12.479

Review 7.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.

Authors:  Ajay Kumar Gupta; Rohan R Naregalkar; Vikas Deep Vaidya; Mona Gupta
Journal:  Nanomedicine (Lond)       Date:  2007-02       Impact factor: 5.307

Review 8.  Magnetic nanoparticles and their applications in medicine.

Authors:  Etienne Duguet; Sébastien Vasseur; Stéphane Mornet; Jean-Marie Devoisselle
Journal:  Nanomedicine (Lond)       Date:  2006-08       Impact factor: 5.307

9.  Hypersensitivity reactions from taxol.

Authors:  R B Weiss; R C Donehower; P H Wiernik; T Ohnuma; R J Gralla; D L Trump; J R Baker; D A Van Echo; D D Von Hoff; B Leyland-Jones
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

10.  Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates.

Authors:  Doaa M Ragab; Sohrab Rohani; Styliani Consta
Journal:  Int J Nanomedicine       Date:  2012-06-29
View more
  1 in total

1.  Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.

Authors:  Nathanael A Stocke; Samantha A Meenach; Susanne M Arnold; Heidi M Mansour; J Zach Hilt
Journal:  Int J Pharm       Date:  2014-12-24       Impact factor: 5.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.